Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × OTHER × Sarcopenia × Clear all

Phase

Phase NA 48 Phase 2 4 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 283 Leukemia, Myeloid, Acute 229 Multiple Myeloma 200 Carcinoma, Non-Small-Cell Lung 196 Prostatic Neoplasms 187 Neoplasms 175 Lymphoma 169 Melanoma 163 Colorectal Neoplasms 163 Leukemia 154 Pancreatic Neoplasms 143 Precursor Cell Lymphoblastic Leukemia-Lymphoma 141 Lung Neoplasms 133 Recurrence 130 Glioblastoma 123 Neoplasm Metastasis 120 Lymphoma, Non-Hodgkin 112 Ovarian Neoplasms 111 Leukemia, Lymphocytic, Chronic, B-Cell 103 Myelodysplastic Syndromes 102 Lymphoma, Large B-Cell, Diffuse 95 Lymphoma, Mantle-Cell 90 Carcinoma, Hepatocellular 89 Brain Neoplasms 83 Stomach Neoplasms 82 Lymphoma, Follicular 82 Hodgkin Disease 80 Carcinoma, Renal Cell 79 Sarcoma 73 Burkitt Lymphoma 64

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07180576 2025-09-18

FORCE

University of Kansas Medical Center

Phase 1/2 Not yet recruiting

Head and Neck Neoplasms, Neoplasms, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡